Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

This study is currently recruiting participants.

Verified May 2013 by Roswell Park Cancer Institute

Study NCT00534118 Information provided by Roswell Park Cancer Institute

First Received on September 20, 2007. Last Updated on May 30, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukemia
Lymphoma
Myelodysplastic Syndromes

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

donor lymphocytes

Sponsors listed in this trial